Loading…

Stepan CoSCLCompetitor analysis, valuation and peers

United States · USD·Materials›Chemicals: Specialty

Makes surfactants and specialty chemicals used in detergents, personal care products and agricultural formulations.

Momentum leader 82
Mkt cap
$1.50B
US dollars, full cap
Free float
95%
of shares outstanding
$/day
$11.5M
20-day average traded
Fwd P/E
20.5×
forward earnings
ROIC−WACC
-4.4 pp
WACC 8.4%
Hurdle
+12 pp
Req g minus delivered
Next earnings
92 days
18 Feb 2027
Close · USD$66.05
1D+0.4%
1W+0.2%
1M+4.5%
3M+3.7%
6M+30.2%
YTD+39.5%
1Y+54.8%
ATR %3.1%
Beta0.62
52w lowhigh9.1% off high

What Stepan does

Makes surfactants and specialty chemicals used in detergents, personal care products and agricultural formulations.

Sells most of its output as surfactants, the cleaning agents in laundry and dish detergents, made from palm kernel oil, coconut oil and petrochemicals, so margins follow the gap between those raw-material costs and selling prices, which are partly passed on to customers. Polymers include polyols for insulation foam.

Products and services

  • Surfactants for detergents/personal care
  • Polymers (polyurethane systems)
  • Specialty products for agriculture and food

Customers

  • Consumer products companies including P&G and Unil
  • Agricultural formulators
  • Industrial manufacturers

Where it sits in the supply chain

  • Materials
  • Chemicals: Specialty
  • Surfactants and specialty chemicals

What could go right

  • Consumer products demand growth
  • Sustainable/green chemistry product mix shift

What could go wrong

  • Raw material (palm/coconut oil, petrochemicals) cost swings
  • Customer inventory destocking cycles

Moat: narrow (process know-how, customer qualification). Long-standing formulation relationships with major consumer products companies, in a competitive commodity-adjacent surfactant market.

Headquarters: Northfield, Illinois, US · Founded: 1932 · Employees: 2,328

Named competitors

Stepan at a glance

Size Stepan (SCL) is a United States Materials company (Chemicals: Specialty) with a market value of $1.50B, the 1973rd largest of 3,085 United States companies the cockpit tracks. Shares closed at $66.05 on 18 Nov 2026.

Performance Over six months the shares gained 30.2%, against -26.8% for the median peer and -2.2% for the United States market (cap-weighted) — highest of 20 in its peer set.

Growth Revenue grew 10.0% over the last twelve months (peer median +16.6%); the operating margin is 3.6% (peer median 7.7%).

Valuation It trades at 20.5× forward earnings against a peer median of 14.0× (7th most expensive of 16).

Price implies For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is +12 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 4.4 points below its cost of capital (8.4% WACC).

Short interest Short interest is 3.0% of the free float (30 Oct 2026).

Next results Next results expected around 18 Feb 2027 (exchange calendar; dates can move).

Relative performance

8010012014021 May 202621 Aug 202618 Nov 2026SCL 129Peer median 70
Six months, rebased to 100: Stepan against the median of its 20 peers (local-currency closes).

Stepan financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$2.53B$2.33B$2.18B$2.33B$2.77B
Revenue growth—+7%-6%-16%—
Gross profit$304M$270M$272M$278M$427M
EBITDA$218M$195M$189M$178M$303M
Net income$4.32M$46.9M$50.4M$40.2M$147M
Free cash flow$4.56M$25.4M$39.3M-$85.5M-$141M
Capital expenditure$110M$123M$123M$260M$302M
Total debt$691M$691M$698M$726M$651M

Quarterly statements and history in the cockpit →

Stepan competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%-20%-10%0%6003664061603826300741603078PRLBSHAILYGEL6030260005530111706039063005763004094046VBK601678CHAMBLFERTSCL6-month return →1-month return →
Up and to the right = strong over both horizons. Stepan is the large dot.

Fundamentals: revenue growth against valuation

0%+25%+50%+75%+100%0×25×50×75×6003664061603826603078PRLBSHAILY6030260005536039063004094046VBK601678CHAMBLFERT4043SCLRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Stepan is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%600366603826300741603078PRLBSHAILYGEL0005534046VBK6016784043SCLGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Stepan is the large dot.

Stepan competitors and peer comparison

Head to head with its named competitors (SCL vs CRDA.L vs BAS.DE)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Stepan SCL$1.50B+30%+10%4%20.5×16.9%
Croda International CRDA.L$7.07B+29%+3%16%24.2×21.0%
Basf BAS.DE$50.1B0%-4%7%15.8×5.7%

How Stepan compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Stepan against its 20 peers (data as of 18 Nov 2026)
MeasureSCLPeer medianRank in peer set
1-month return+4.5%-13.1%highest of 21
6-month return+30.2%-26.8%highest of 20
Distance from 52-week high-9.1%-45.3%highest of 21
Revenue growth (TTM)+10.0%+16.6%6th lowest of 20
Operating margin3.6%7.7%5th lowest of 21
Forward P/E20.5×14.0×7th most expensive of 16
Growth the price implies (Req g, 7 yrs)16.9%11.7%7th least demanding of 13
Growth delivered (Del g)+4.5%+7.6%7th highest of 13
Hurdle (Req g minus delivered)+12.4 pp+5.4 pp5th most demanding of 13
ROIC minus cost of capital-4.4 pp-0.8 pp7th lowest of 21
EV / EBITDA9.6×7.7×3rd most expensive of 9
Net debt / EBITDA2.7×0.5×4th most indebted of 10

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Stepan SCLUnited States$1.50B+30%+10%4%20.5×16.9%+4.5%
Standard Nuclear STDNUnited States$1.50Bn/an/a-288%n/an/an/a
Ningbo Yunsheng 600366.SSChina$1.50B-30%+33%6%17.7×17.5%+17.9%
Denka 4061.TJapan$1.50B-27%0%10%13.2×n/an/a
Fujian Kuncai Material Technology 603826.SSChina$1.50B-56%+59%5%55.8×22.8%+11.0%
Huabao Technology 300741.SZChina$1.49B+4%+17%1%n/a42.0%-8.5%
Jiangyin Jianghua Micro-electronics Materials 603078.SSChina$1.49B-19%+18%7%83.1×34.6%+17.0%
Proto Labs PRLBUnited States$1.53B-10%+12%8%26.7×26.6%+4.2%
Shaily Engineering Plastics SHAILY.NSIndia$1.53B+18%+18%24%57.7×36.4%+22.8%
Genesis Energy, L.P GELUnited States$1.54B-23%-2%18%n/a3.1%-2.2%
Shida Shinghwa Advanced Material 603026.SSChina$1.46B-58%+58%8%6.5×n/an/a
ADAMA 000553.SZChina$1.46B-36%-6%3%28.9×-7.7%+0.3%
LOTTE CHEMICAL 011170.KSSouth Korea$1.46B-51%+11%-3%n/an/an/a
Jiangsu Lopal Tech 603906.SSChina$1.56B-51%+96%7%12.6×n/an/a
Shenzhen Rongda Photosensitive & Technology 300576.SZChina$1.44B-39%+14%10%n/an/an/a
Guangdong Dowstone Technology 300409.SZChina$1.44B-49%+34%6%12.7×n/an/a
Osaka Soda 4046.TJapan$1.58B+3%+13%19%14.0×6.0%+0.5%
Verbio VBK.DEGermany$1.58B-42%+19%8%13.0×-10.2%+12.8%
Befar 601678.SSChina$1.42B-25%+19%5%20.6×-7.0%+18.2%
Chambal Fertilisers & Chemicals CHAMBLFERT.NSIndia$1.59B-18%+6%12%7.4×n/an/a
Tokuyama 4043.TJapan$1.59B-23%+7%9%5.9×1.3%+2.9%

Questions

Who are Stepan's main competitors?
Named competitors: Croda International (CRDA.L), BASF (BAS.DE), Solvay (private or unlisted). The cockpit's measured peer set (industry) also includes Standard Nuclear (STDN), Ningbo Yunsheng (600366.SS), Denka (4061.T), Fujian Kuncai Material Technology (603826.SS), Huabao Technology (300741.SZ), Jiangyin Jianghua Micro-electronics Materials (603078.SS).
Is Stepan expensive compared with its peers?
On forward p/e it trades at 20.5× against a peer median of 14.0×, 7th most expensive of 16 in its peer set. For today's price to make sense, revenue must grow about 17% a year for seven years (Req g). Recent delivered growth is +5%, so the hurdle is +12 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Stepan stock performed?
Over six months to 18 Nov 2026 the shares returned +30.2% against -26.8% for the median peer; over one year +54.8%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.